Active Litigation
Kratom Lawsuit Facts
TorHoerman Law is investigating claims for the Kratom Lawsuit.
Active Litigation
TorHoerman Law is investigating claims for the Kratom Lawsuit.
A kratom overdose can cause severe respiratory depression, seizures, loss of consciousness, and potentially fatal medical complications.
Overdose risks vary depending on the product’s alkaloid concentration, the amount consumed, and whether other drugs or alcohol are involved.
Concentrated kratom extracts and products containing enhanced levels of 7-hydroxymitragynine (7-OH) present additional concerns because their effects can differ substantially from traditional kratom leaf preparations.
TorHoerman Law is investigating potential claims involving serious kratom overdose injuries and deaths allegedly associated with inadequate product warnings or unsafe formulations.

Kratom contains compounds that interact with opioid receptors in the brain, creating the potential for opioid-like toxicity under certain circumstances.
A person experiencing severe kratom toxicity may develop dangerously slow breathing, become unresponsive, or experience a seizure.
Some overdoses involve traditional kratom powders or capsules, while others involve concentrated liquid extracts, shots, gummies, tablets, or products containing added 7-OH.
The composition and strength of these products can vary considerably, making the amount of active alkaloids consumed difficult to determine.
Medical studies and reports to poison control centers have documented kratom-associated hospitalizations and deaths, frequently involving exposure to multiple substances.
Not every reported kratom exposure is an overdose, and detecting kratom during toxicology testing does not automatically establish that it caused an injury or death.
Our attorneys review potential claims involving overdose-related injuries, including respiratory failure, hypoxic brain injury, and fatal intoxication.
These claims are part of our broader kratom lawsuit investigation.
Call TorHoerman Law today for a free consultation, or use the chat feature on this page to discuss a potential kratom overdose claim.
Yes, taking kratom can result in an overdose, including life-threatening toxicity involving the respiratory, cardiovascular, and nervous systems.
Kratom is an herbal substance derived from Mitragyna speciosa, a tropical tree native to Southeast Asia.
Its principal active alkaloid, mitragynine, and the more potent compound 7-hydroxymitragynine act on some of the same opioid receptors affected by prescription opioids, though kratom does not necessarily produce the same effects or risks as those drugs.
People report stimulant effects, such as increased alertness, at low doses and more sedating, opioid-like effects at higher doses.
The National Institute on Drug Abuse cautions that research has not established a predictable dose-response relationship across products.
The response depends on product composition, dose, individual physiology, and other substances consumed.
At toxic levels, kratom exposure may cause profound sedation, impaired consciousness, seizures, and respiratory depression.
Some patients instead present with agitation, nausea, stomach pain, or a rapid heart rate rather than the classic signs of opioid toxicity.
There is no established kratom dose that reliably separates safe use from overdose across all products and individuals.
The U.S. Food and Drug Administration (FDA) warns about serious adverse effects associated with kratom, including seizures, liver toxicity, substance use disorder, and deaths reported in connection with its use.
The agency has not approved kratom for pain relief, opioid withdrawal, or any other medical condition.
The Drug Enforcement Administration lists kratom as a Drug and Chemical of Concern, but ordinary kratom leaf is not generally scheduled as a controlled substance under federal law.
The DEA has separately taken action concerning certain concentrated or laboratory-made kratom-related compounds; the federal status of whole-leaf kratom should not be mistaken for a safety determination or FDA approval.
A kratom overdose occurs when exposure to the product’s active compounds produces toxic effects that exceed the body’s ability to tolerate or compensate for them.
There is no single mechanism or exposure pattern responsible for every reported overdose.
Circumstances associated with increased overdose risk include:
A person may also be unaware that two products sold under similar descriptions contain substantially different quantities of active alkaloids.
Traditional kratom leaf contains mitragynine as its primary alkaloid and much smaller natural amounts of 7-hydroxymitragynine.
Some kratom-containing products contain concentrated extracts, isolated alkaloids, or additional 7-OH.
These formulations, which may be sold online or in smoke shops alongside conventional kratom powder, should not be assumed to have the same potency or risk profile as ordinary kratom leaf.
The FDA identifies concentrated 7-OH as a potent opioid-like substance and has raised specific concerns about its effects on consumers.
Products containing enhanced 7-OH may be sold as tablets, gummies, liquid shots, or drink mixes, sometimes alongside conventional kratom products.
In July 2025, the FDA issued warning letters concerning concentrated 7-OH products.
The agency subsequently warned consumers that these products have not been established as safe or effective for medical use.
A product labeled as kratom does not necessarily contain the same proportions of active compounds as traditional kratom leaf.
For an overdose investigation, the specific formulation and concentration may be more informative than the product’s general description.
Kratom products vary in their composition, serving instructions, and concentrations of active alkaloids.
A person may take higher doses because the initial amount did not produce the expected effects, including anticipated pain relief or mood enhancement.
That behavior can increase exposure, particularly when using concentrated extracts or products with unclear potency information.
Repeated kratom use may also produce tolerance and physical dependence.
Tolerance to certain subjective effects does not eliminate the possibility of toxic reactions, and it does not establish that progressively larger doses are safe.
Overdose risk cannot be reliably determined from the number of capsules, gummies, or bottles consumed without understanding what those products contained.
Mixing kratom with other substances can increase the risk of severe toxicity.
Its opioid-like properties may overlap with the sedating or respiratory-depressant effects of prescription drugs, illicit opioids, benzodiazepines, and alcohol.
Substances of particular concern include:
Kratom alkaloids may also affect enzymes involved in metabolizing certain medications, although the clinical significance depends on the specific drugs and circumstances.
The CDC’s March 2026 poison center analysis found that reports involving kratom and additional substances were associated with higher hospitalization rates and more serious outcomes than reports involving kratom alone.
These findings do not establish that every drug combination produces the same degree of risk.
They do show that identifying co-occurring substances is important when clinicians evaluate a suspected overdose, particularly when a drug use history is incomplete.
Kratom overdose symptoms can involve several organ systems and do not always resemble a typical opioid overdose.
Some people experience prominent nausea, agitation, or rapid heartbeat, while others develop severe sedation or difficulty breathing.
Reported symptoms of kratom toxicity include:
The presence of one symptom does not necessarily establish an overdose.
However, worsening consciousness, breathing abnormalities, or seizures can indicate a medical emergency regardless of the amount reportedly consumed.
Respiratory depression occurs when breathing becomes dangerously slow or ineffective.
As oxygen levels decline, a person may become increasingly difficult to wake or stop responding normally.
Severe oxygen deprivation can injure the brain and other organs.
Call 911 immediately if someone who has used kratom develops any of the following:
A suspected overdose should not be dismissed because the person used a product sold as herbal or natural.
The precise cause may be uncertain during the emergency, particularly when other medications or substances are involved.
A suspected kratom overdose involving abnormal breathing, unconsciousness, or seizures requires emergency medical assistance.
Do not wait for the person to recover without treatment.
Immediate steps include:
The CDC’s overdose response guidance emphasizes giving naloxone when appropriate, contacting emergency services, supporting breathing, and remaining with the person.
Naloxone can reverse opioid-induced respiratory depression, but it is not a complete treatment for every complication of kratom toxicity.
A person should still receive medical evaluation even if breathing or consciousness improves.
For a non-emergency suspected exposure, the Poison Help service can provide guidance.
There is no single treatment that reverses every effect of kratom toxicity.
Emergency clinicians generally provide supportive care based on the patient’s breathing, consciousness, cardiovascular status, and other symptoms.
Treatment also depends on whether the person consumed additional substances.
Hospital care may involve:
Clinicians may evaluate kidney and liver function, electrolyte abnormalities, oxygen levels, and possible consequences of seizures or prolonged unconsciousness.
Not every patient requires intensive care, but severe respiratory depression or recurrent symptoms may justify extended monitoring.
Naloxone may improve breathing in some patients experiencing kratom-associated opioid-like toxicity.
Because kratom alkaloids interact with opioid receptors, naloxone is sometimes administered when a person presents with signs resembling an opioid overdose.
The response is not predictable, and naloxone does not reverse every possible complication of kratom poisoning.
A 2023 published case report described a woman who became unresponsive and developed dangerously low oxygen levels after consuming kratom capsules and a concentrated extract.
Her condition initially improved after naloxone and respiratory support, but her oxygen levels declined again during emergency department observation.
The authors reported that Poison Control warned of possible rebound respiratory depression and rebound hypoxia during the 12 to 24 hours after ingestion in this case.
A 2026 review of kratom toxicity also discusses variable naloxone responses and delayed or recurrent respiratory depression.
These reports support medical observation when symptoms recur or clinicians suspect ongoing toxicity, but they do not establish a universal 12-to-24-hour risk window or identical observation requirements for every patient.
Routine emergency department urine drug screens generally do not include tests specifically designed to detect mitragynine or 7-OH.
A negative routine opioid screen therefore does not rule out kratom exposure.
Specialized analytical testing may identify kratom alkaloids when it is available and medically appropriate.
Clinicians also rely on reported product use, physical findings, the timing of symptoms, and information about other substances.
A positive kratom result does not independently establish that kratom caused every symptom.
Likewise, a negative routine screening result does not prove that a patient was not experiencing kratom-related toxicity.
These limitations are particularly relevant when a person presents with respiratory depression or neurological symptoms and the substances involved are initially uncertain.
Some patients recover from kratom toxicity following medical treatment without lasting impairment.
Others may experience prolonged consequences, particularly if the overdose caused substantial oxygen deprivation, seizures, respiratory failure, or other serious complications.
Long-term outcomes depend on the nature and severity of the medical emergency.
Potential complications following severe toxicity include:
These outcomes are possible consequences of severe poisoning and related medical emergencies.
They should not all be described as common or inevitable effects of kratom overdose.
Chronic kratom use can also cause dependence and withdrawal symptoms, including muscle aches, gastrointestinal distress, restlessness, and anxiety after use stops.
Those symptoms are distinct from the acute respiratory and neurological emergencies described on this page, although a person may need treatment for both overdose-related injuries and a substance use disorder.
Treatment may need to address physical recovery and mental health needs without confusing withdrawal with acute poisoning.
Federal surveillance reports document increasing kratom-related poison center exposures and deaths in which kratom was detected or identified as a contributing factor.
The reports require careful interpretation because a reported exposure is not necessarily a medically confirmed overdose.
On March 26, 2026, the CDC published an analysis of kratom-related poison center reports from 2015 through 2025.
Researchers identified 14,449 reports during the 11-year period.
Annual reports increased from 258 in 2015 to 3,434 in 2025, an increase of approximately 1,200%.
The study found that multiple-substance exposure reports were associated with more serious medical outcomes and higher hospitalization rates.
Researchers identified 233 deaths associated with reported kratom exposures, with 184 involving multiple substances.
That means approximately 79% of the reported deaths involved kratom alongside at least one other substance.
Opioids were reported in 62% of the fatalities, while benzodiazepines, stimulants, and alcohol were also documented.
These figures describe reported exposures and associated outcomes.
They do not demonstrate that kratom was the sole cause of every hospitalization or death.
The CDC also noted that the sharp increase in 2025 coincided with the growing availability of concentrated kratom alkaloid products, without establishing that those products caused the increase.
An earlier CDC report published in April 2019 reviewed overdose deaths recorded across participating states between July 2016 and December 2017.
Researchers identified 152 kratom-positive overdose decedents whose postmortem toxicology results detected the substance.
Medical examiners or coroners determined that kratom contributed to 91 of those deaths.
Seven of the 91 cases involved kratom as the only substance detected, although the CDC cautioned that undetected substances could not be ruled out.
Fentanyl, heroin, benzodiazepines, and other drugs were frequently identified alongside kratom.
These findings document the possible involvement of kratom in fatal overdoses while demonstrating the limitations of attributing a death to a single substance when several drugs were present.
When someone dies after using kratom, investigators may need to determine whether the death resulted from acute mitragynine intoxication, enhanced 7-OH exposure, another drug, or a combination of factors.
Medical examiners may use autopsy findings, toxicology testing, clinical history, and information about the circumstances surrounding the death.
Kratom alkaloid concentrations alone do not provide a universally reliable threshold for declaring an overdose fatal.
Some forensic studies associate higher mitragynine blood levels with fatal cases, but a measured concentration is not, by itself, proof of overdose causation.
Individual tolerance, product composition, the timing of exposure, co-occurring substances, and underlying medical conditions can affect the interpretation.
Some fatal cases have been attributed to acute mitragynine intoxication, while others involve combined drug toxicity.
Families considering legal action following a suspected fatal overdose can find broader information about eligibility, product liability, and wrongful death claims in our kratom lawsuit investigation.
Our attorneys are reviewing potential cases involving serious overdose injuries and deaths following the use of kratom powders, capsules, extracts, concentrated shots, and enhanced 7-OH products.
These cases may involve allegations that a manufacturer or seller inadequately disclosed overdose risks, product potency, or dangerous interactions with other substances.
The circumstances of the overdose, the product involved, and the available medical findings determine whether a potential legal claim can be supported.
Call TorHoerman Law today or contact our firm for a free consultation. You can also use the chat feature on this page.
Yes.
Serious toxicity and overdose have been reported following kratom exposure without another substance being identified.
However, many severe and fatal cases involve additional medications or drugs, and the contribution of each substance requires individual assessment.
The absence of other known drugs does not make a suspected kratom overdose harmless.
Concentrated products containing added or enhanced 7-hydroxymitragynine raise distinct safety concerns because 7-OH has substantially greater opioid-receptor activity than mitragynine.
The FDA has specifically warned about these formulations, which may contain concentrations far exceeding the naturally occurring amounts found in kratom leaves.
The actual risk depends on product composition, exposure, and other individual factors.
Symptoms may develop after ingestion, but there is no reliable onset time that applies to every kratom formulation.
The timing depends on the product, the amount used, other substances, and individual factors.
A person who becomes unusually drowsy, confused, unresponsive, or has difficulty breathing after using kratom needs medical evaluation rather than waiting for a particular amount of time to pass.
Naloxone may improve opioid-like respiratory depression in some cases, but responses to kratom-associated toxicity vary.
It does not treat every complication of poisoning, including seizures or injuries from prolonged oxygen deprivation.
Emergency medical care remains necessary even when someone initially improves after naloxone administration.
Routine urine drug screens do not reliably identify kratom alkaloids.
Specialized testing may detect mitragynine or 7-OH, but it may not be immediately available during emergency treatment.
Clinicians therefore consider the patient’s symptoms, reported exposure, other medications, and available testing.
Neither a positive result nor a negative routine drug screen independently determines the cause of an overdose.
Some patients recover after supportive care, particularly when breathing and other vital functions are restored promptly.
Severe cases involving prolonged oxygen deprivation, seizures, or organ injury can lead to lasting complications.
The likelihood of recovery depends on the individual medical circumstances rather than a universal recovery period.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Kratom Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.